Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deacon

Showing results (291-300 of 2,132) with videos related to

Pageof 214
Sort By:
Plos One|September 26, 2015
Limited Pollen Dispersal Contributes to Population Genetic Structure but Not Local Adaptation in Quercus oleoides Forests of Costa RicaNicholas John Deacon, Jeannine Cavender-Bares
Diabetes, Obesity & Metabolism|November 25, 2015
Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureasC F Deacon, H E Lebovitz
Behavior Modification|September 27, 2012
Dissemination of evidence-based practices for anxiety disorders in Wyoming: a survey of practicing psychotherapistsLeilani J Hipol, Brett J Deacon
Annals of Clinical Biochemistry|May 23, 1998
Limitations of solvent fractionation methods for urinary and faecal porphyrinsA C Deacon, J A Ledden
Journal of the American Chemical Society|April 11, 2025
Sulfenylcarbene-Mediated Carbon Atom Insertion for the Late-Stage Functionalization of <i>N</i>-HeterocyclesPrakash Kafle, Deacon Herndon, Indrajeet Sharma
Perioperative Nursing Quarterly|June 1, 1985
Primer on organizing microsurgical procedures more effectivelyC M Deacon, C Wafle-Guenther
Canadian Family Physician Medecin De Famille Canadien|February 8, 2011
The prenatal assessment of fetal healthJ Parboosingh, J Mousseau, J Deacon
Current Opinion in Pharmacology|November 5, 2004
Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitusJens Juul Holst, Carolyn F Deacon
Thrombosis Et Diathesis Haemorrhagica|April 30, 1975
Scanning electron microscopic and electrophoretic observations on barium sulphate used to absorb clotting factorsR M Howell, S L Deacon
Expert Opinion on Investigational Drugs|December 2, 2009
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetesCarolyn F Deacon, Jens J Holst
Pageof 214

Showing results (291-300 of 2,132) with videos related to

Sort By:
Pageof 214
Plos One|September 26, 2015
Limited Pollen Dispersal Contributes to Population Genetic Structure but Not Local Adaptation in Quercus oleoides Forests of Costa RicaNicholas John Deacon, Jeannine Cavender-Bares
Diabetes, Obesity & Metabolism|November 25, 2015
Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureasC F Deacon, H E Lebovitz
Behavior Modification|September 27, 2012
Dissemination of evidence-based practices for anxiety disorders in Wyoming: a survey of practicing psychotherapistsLeilani J Hipol, Brett J Deacon
Annals of Clinical Biochemistry|May 23, 1998
Limitations of solvent fractionation methods for urinary and faecal porphyrinsA C Deacon, J A Ledden
Journal of the American Chemical Society|April 11, 2025
Sulfenylcarbene-Mediated Carbon Atom Insertion for the Late-Stage Functionalization of <i>N</i>-HeterocyclesPrakash Kafle, Deacon Herndon, Indrajeet Sharma
Perioperative Nursing Quarterly|June 1, 1985
Primer on organizing microsurgical procedures more effectivelyC M Deacon, C Wafle-Guenther
Canadian Family Physician Medecin De Famille Canadien|February 8, 2011
The prenatal assessment of fetal healthJ Parboosingh, J Mousseau, J Deacon
Current Opinion in Pharmacology|November 5, 2004
Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitusJens Juul Holst, Carolyn F Deacon
Thrombosis Et Diathesis Haemorrhagica|April 30, 1975
Scanning electron microscopic and electrophoretic observations on barium sulphate used to absorb clotting factorsR M Howell, S L Deacon
Expert Opinion on Investigational Drugs|December 2, 2009
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetesCarolyn F Deacon, Jens J Holst
Pageof 214